08/26/2014 - 10:45am

Fera Pharmaceuticals on Monday announced that it was selected by Pragma Pharmaceuticals to launch amoxicillin extended-release tablets

08/25/2014 - 6:55pm

DSN presents a preview of some of the hottest pharmacy and technology products that will appear on the show floor at NACDS Total Store Expo.

08/25/2014 - 3:23pm

Pharmacy health information technology has come a long way in the past five years, but there is still a significant amount of opportunity for pharmacy operations to plug into the HIT network — opportunities that will augment pharmacy’s value to the healthcare system in improving adherence and reducing abandonment.

08/25/2014 - 3:17pm

With diabetes and other diseases at epidemic levels, the need for more pharmacies to step up and offer accessible, convenient patient screening for a variety of serious and even life-threatening conditions is clear, a panel of pharmacists asserted at Monday’s “Convenient Care — Point of Care Testing in the Pharmacy” session.

08/25/2014 - 12:58pm

Emdeon on Monday announced the launch of Emdeon Easy Save for retail pharmacies. The program gives access to some of the largest co-pay assistance programs available, while also encouraging retail pharmacies to offer co-pay coupon programs to customers when they need it, according to the company.

08/25/2014 - 12:20pm

Nipro Diagnostics announced that the Food and Drug Administration approved its True Metrix self-monitoring blood-glucose system, as well as the True Metrix Pro professional monitoring blood-glucose system.

08/25/2014 - 12:16pm

Pharmaceutical company Iroko announced today that a new version its anti-inflammatory drug Zorvolex had been approved by the Food and Drug Administration.

08/25/2014 - 11:56am

ViiV Healthcare announced that the Food and Drug Administration has approved Triumeq (abacavir 600 mg, dolutegravir 50 mg and lamivudine 300 mg) tablets for the treatment of HIV-1 infection.

08/25/2014 - 10:20am

Biotech company Roche will be acquiring research and pharmaceutical company InterMune for $8.3 billion, it announced over the weekend.